For example, we propose that their high affinity toward TTR may compromise their functionality as effective TRβ activators, resulting in reduced multi-functional activity as a therapeutic molecule for TTR amyloidosis, or related pathologies. The gene discussed is THRB; the disease is familial amyloid neuropathy.